ArticleJournal of translational medicine2015

miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase.

Huiyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.